Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05627362 |
| Consolidated Lead Sponsor | Ipsen |
| Therapeutic Condition Cohort | Gastroenterology, Hepatology, and Renal |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 68 participants (ACTUAL) |
| Registered Start Date | 2022-12-29 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Om Research LLC | Lancaster, CA | Open Hospital Dossier -> |
| Cedars-Sinai Medical Center | Los Angeles, CA | Open Hospital Dossier -> |
| UC Davis Comprehensive Cancer Center | Sacramento, CA | Open Hospital Dossier -> |
| Yale Cancer Center and Smilow Cancer Hospital | New Haven, CT | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.